Lori Y. Kam

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease

Marla C. Dubinsky, Huiying Yang, Philip V. Hassard et al. · Gastroenterology · 2002 · 483 citations · Full text

Inflammation, 6-Mp Metabolite Profiles, Medicine +10

Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease

María T. Abreu, Kent D. Taylor, Ying–Chao Lin et al. · Gastroenterology · 2002 · 429 citations

Fibrosis, Autoimmune Disease, Disease Mechanism +7

Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.

Vincenzo Casini–Raggi, Lori Y. Kam, Yueyang Chong et al. · The Journal of Immunology · 1995 · 409 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Il-1 Receptor Antagonist +14

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease

Eric A. Vasiliauskas, Lori Y. Kam, Maria T. Abreu-Martin et al. · Gastroenterology · 1999 · 286 citations · Full text

Open-label Pilot Study, Steroid-dependent Crohn, Gastrointestinal Pharmacology +7

Outcome of cytomegalovirus infections in patients with inflammatory bowel disease

Konstantinos Papadakis, Scott W. Binder, Lori Y. Kam et al. · The American Journal of Gastroenterology · 2001 · 237 citations

Autoimmune Disease, Immunodeficiencies, Immunology +10